MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Other Accumulated Expenses of $50.3 million for Q4 2025, up 5468.44% on a YoY basis from $903000.0 in Q4 2024, and up 6750.54% quarter-over-quarter from $734000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Other Accumulated Expenses for 9 years, with the latest figure at $50.3 million in Q4 2025.
- For the quarter ending Q4 2025, Other Accumulated Expenses rose 5468.44% year-over-year to $50.3 million; the trailing twelve-month figure through Dec 2025 stood at $50.3 million (up 5468.44% YoY), and the FY2025 full-year result was $50.3 million, up 5468.44% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $50.3 million, up from $734000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $50.3 million in Q4 2025, with the low at $134000.0 in Q2 2021.
- Historically, Other Accumulated Expenses has averaged $3.5 million across 5 years, with a median of $595000.0 in 2021.
- The largest YoY upside for Other Accumulated Expenses was 5468.44% in 2025 against a maximum downside of 84.71% in 2025.
- MeiraGTx Holdings' Other Accumulated Expenses stood at $456000.0 in 2021, then surged by 1354.17% to $6.6 million in 2022, then slumped by 80.73% to $1.3 million in 2023, then dropped by 29.34% to $903000.0 in 2024, then jumped by 5468.44% to $50.3 million in 2025.
- The last three Other Accumulated Expenses figures came in at $50.3 million (Q4 2025), $734000.0 (Q3 2025), and $160000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.28 Mn |
| Sep 30, 2025 | 734,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | 903,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 260,000.00 |
| Mar 31, 2023 | 2.57 Mn |
| Dec 31, 2022 | 6.63 Mn |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 983,000.00 |
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 456,000.00 |
| Sep 30, 2021 | 328,000.00 |
| Jun 30, 2021 | 134,000.00 |
| Mar 31, 2021 | 442,000.00 |